Search

Your search keyword '"Gillies A"' showing total 579 results

Search Constraints

Start Over You searched for: Author "Gillies A" Remove constraint Author: "Gillies A" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
579 results on '"Gillies A"'

Search Results

1. Figure S1 from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

2. Data from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

3. Supplemental Figure Legends from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

4. Figure S1 from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

5. Data from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

6. Supplemental Figure Legends from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

7. Supplemental Figure 6 from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma

8. Data from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

9. Figure S3 from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

10. Figure S6 from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

11. Table S1 from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

12. Supplemental Material from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution

13. SUPPLEMENTAL MATERIALS from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

14. Data from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models

15. Data from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma

17. Supplementary Figure 5 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

18. Data from Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer

19. Table S1 from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

20. Data from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

21. Supplemental Figures and Tables from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma

22. Supplementary figure legends from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

23. Supplementary Figure 3 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

24. Supplementary Methods from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

25. Supplementary Methods from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

26. Supplementary FIgure 2 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

27. Table S3 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

28. Supplementary Table S3 from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models

29. Data from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution

30. Supplementary Figures 1-6 from Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes

31. Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer

32. Supplementary Material and Methods from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models

33. Supplementary Data from A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma

34. Supplementary Figure 1 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

36. Supplementary Table S1 from Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

37. Supplementary Methods from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

38. Supplementary Figure 4 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer

39. Data from Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

42. Supplementary Figures from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models

44. Supplemental Figure 6 from In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

46. Supplemental Figure 5 from In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

50. Supplementary Figure 3 from Acidity Generated by the Tumor Microenvironment Drives Local Invasion

Catalog

Books, media, physical & digital resources